Anti-Human CA9 Recombinant Antibody

Product Information

Catalog Number	YR1222
Product Name	Anti-Human CA9 Recombinant Antibody
Molecular Name	Girentuximab
Alias	Anti-CA9 Recombinant Antibody, Research Grade Girentuximab
CAS Number	916138-87-9
Target	CA9[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Host	Mouse
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	WB, FuncS, IF, Neut, ELISA, FCM, IP, PK, IHC, Activ
Buffer	PBS, pH7.5
Background	Girentuximab (trade name Rencarex) is a chimeric IgG1 monoclonal antibody to carbonic anhydrase IX (CAIX). CAIX is expressed on the surface of most renal cancer cells and is hypothesized to be on the surface of other tumor cells. It is investigational agent in clinical trials for renal cell carcinoma. Its development was suspended as a "naked" or unconjugated antibody during phase III trials due to efficacy.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price